Association of pharyngitis with oral antibiotic use for the treatment of acne: A cross-sectional and prospective cohort study

Archives of Dermatology

Volumn 148, Issue 3, 2012, Pages 326-332

  Margolis, David J ^a   Fanelli, Matthew ^a   Kupperman, Eli ^a   Papadopoulos, Maryte ^a   Metlay, Joshua P ^a   Xie, Sharon Xiangwen ^a   DiRienzo, Joseph ^a   Edelstein, Paul H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACNE; ADULT; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN EXAMINATION; STREPTOCOCCUS GROUP A;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PHARYNGITIS; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84858741723     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.355     Document Type: Article

References (35)

1. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
2. Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J Drugs Dermatol. 2010;9(6):655-664.
3. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629-641.
4. Meropol SB, Chan KA, Chen Z, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008;17(5):523-532. (Pubitemid 351722040)
5. Leyden JJ. Therapy for acne vulgaris. N Engl J Med. 1997;336(16):1156- 1162.
6. Gollnick H, Cunliffe W, Berson D, et al Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1)(suppl):S1-S37. (Pubitemid 36791495)
7. Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol. 2011;147(8): 917-921.
8. Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005; 141(9):1132-1136.
9. Bowe WP, Hoffstad O, Margolis DJ. Upper respiratory tract infection in household contacts of acne patients. Dermatology. 2007;215(3):213-218. (Pubitemid 47378988)
10. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139(4): 467-471. (Pubitemid 36427611)
11. Levy RM, Leyden JJ, Margolis DJ. Colonisation rates of Streptococcus pyogenes and Staphylococcus aureus in the oropharynx of a young adult population. Clin Microbiol Infect. 2005;11(2):153-155. (Pubitemid 40253822)
12. Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006;5(9):868-870.
13. Huskins WC, Kaplan EL. Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci. Epidemiol Infect. 1989;102(3):401-412. (Pubitemid 19166871)
14. Schroeder BM. Diagnosis and management of group A streptococcal pharyngitis. Am Fam Physician. 2003;67(4):880-884, 883-884.
15. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; Infectious Diseases Society of America. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis. 1997;25(3):574-583. (Pubitemid 127774276)
16. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. Washington, DC: ASM Press; 2006.
17. Igarashi T, Yano Y, Yamamoto A, Sasa R, Goto N. Identification of Streptococcus salivarius by PCR and DNA probe. Lett Appl Microbiol. 2001;32(6):394- 397.
18. Ross KF, Ronson CW, Tagg JR. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol. 1993;59(7):2014-2021. (Pubitemid 23205782)
19. Tagg JR, Bannister LV. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol. 1979; 12(4):397-411. (Pubitemid 10107092)
20. Walls T, Power D, Tagg J. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol. 2003;52(pt 9):829-833. (Pubitemid 37174788)
21. Clinical and Laboratory Standards Institute. M100-S17: Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
22. Stiratelli R, Laird NM, Ware JH. Random-effects models for serial observations with binary response. Biometrics. 1984;40(4):961-971.
23. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923-936. (Pubitemid 24002359)
24. Localio AR, Margolis DJ, Berlin JA. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol. 2007;60(9):874-882. (Pubitemid 47208538)
25. Oberemok SS, Shalita AR. Acne vulgaris, I: pathogenesis and diagnosis. Cutis. 2002;70(2):101-105. (Pubitemid 41757461)
26. Oberemok SS, Shalita AR. Acne vulgaris, II: treatment. Cutis. 2002;70(2):111-114. (Pubitemid 41757463)
27. Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol. 2007;157(3):540-546. (Pubitemid 47256131)
28. Margolis DJ. Antibiotics, acne, and upper respiratory tract infections. LDI Issue Brief. 2006;11(4):1-4.
29. Begovac J, Bobinac E, Benic B, et al. Asymptomatic pharyngeal carriage of betahaemolytic streptococci and streptococcal pharyngitis among patients at an urban hospital in Croatia. Eur J Epidemiol. 1993;9(4):405-410. (Pubitemid 23291528)
30. Hoffman S. The throat carrier rate of group A and other beta hemolytic streptococci among patients in general practice. Acta Path Microbiol Immunol Scand. 1985;93:347-351.
31. Strömberg A, Schwan A, Cars O. Throat carrier rates of beta-hemolytic streptococci among healthy adults and children. Scand J Infect Dis. 1988;20(4):411- 417.
32. Tompkins GR, Tagg JR. The ecology of bacteriocin-producing strains of Streptococcus salivarius. Microb Ecol Health Dis. 1989;2:19-28.
33. Grice EA, Kong HH, Conlan S, et al NISC Comparative Sequencing Program. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-1192.
34. Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med. 2002;44(9):822-829. (Pubitemid 34988572)
35. Fendrick AM,Monto AS, Nightengale B, Sarnes M. The economic burden of noninfluenza- related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487-494. (Pubitemid 36244917)